Observational studyBreast cancer research and treatment2026

Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors.

Nicole L Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.